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Background: To investigate whether the GPDS1 locus, a potential causative locus of 
pigment-dispersion syndrome, is associated with normal-tension glaucoma (NTG) in Japanese 
patients.
Materials and methods: We used polymerase chain reaction ampliﬁ  cation with sequence-
speciﬁ  c primers to analyze 20 polymorphic microsatellite markers in and around the GPDS1 
locus with an automated DNA analyzer and automated fragment detection by ﬂ  uorescent-based 
technology. The DNA samples used for these analyses were obtained from ethnicity- and gender-
matched patients, including 141 Japanese patients with NTG and 101 healthy controls. Patients 
exhibiting a comparatively early onset were selected as this suggests that genetic factors may 
show stronger involvement.
Results: One allele of D7S2462 exhibited a frequency that was signiﬁ  cantly decreased in NTG 
cases compared to controls (P = 0.0013, Pc = 0.019, OR = 0.48, 95% CI = 0.30–0.75). Alleles at 
another six microsatellite loci were positively or negatively associated with NTG, but these associa-
tions did not retain statistical signiﬁ  cance after Bonferroni correction (P  0.05, Pc  0.05).
Conclusion: Our study showed a signiﬁ  cant association between the GPDS1 locus and NTG, 
suggesting that there may be some genetic risk factor(s) in the development of NTG.
Keywords: microsatellite, normal tension glaucoma, glaucoma-related pigment dispersion 
syndrome, GPDS1, DPP6
Background
Glaucoma is the second most common cause of blindness worldwide.1 This condition 
has a high socioeconomic impact, affecting over 67 million people in the western 
world.2 The disease is characterized by a loss of visual ﬁ  eld corresponding to the 
excavation of the optic disc. It is considered to be a multifactorial disorder that occurs 
because of the interaction of genetic and environmental factors. In addition to an 
association with intraocular pressure (IOP), the onset and progression of glaucoma 
is involved with several other risk factors, including ischemia, refraction, systemic 
illness, and genetic predisposition.
Primary open-angle glaucoma (POAG) is usually associated with elevated IOP. 
The pathogenesis of glaucomatous optic neuropathy is not completely understood, 
although elevated IOP is a generally accepted major risk factor for this condition. 
Normal-tension glaucoma (NTG) is an important subtype of POAG and accounts for 
approximately one-third of all POAG cases in Caucasians.3 Notably, the incidence of 
NTG is higher in Japan than in the western world, and it occurs in approximately 92% of 
all Japanese POAG patients, as reported in the Tajimi Study.4 The IOP of  NTG patients 
consistently lies within the statistically normal range; thus, although IOP is suggested 
to play a role in the development of NTG, its involvement may be less in NTG than 
that in high-tension glaucoma (HTG). Other pathogenic factors such as vasospasm, Clinical Ophthalmology 2009:3 308
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ischemia, and vascular insufﬁ  ciencies are indicated to be 
associated with the development of NTG.5–8
Pigment dispersion syndrome (PDS) and pigmentary 
glaucoma (PG) are characterized by a disruption of iris pig-
ment epithelium and deposition of the dispersed pigment 
granules throughout the anterior segment. The classic diag-
nostic triad consists of corneal pigmentation (Krukenberg 
spindle); slit-like, radial, or mid-peripheral iris transillumi-
nation defects; and dense trabecular pigmentation.9 PDS/PG 
usually affects individuals under the age of 30 years. In the 
early stages of the disease, affected individuals may exhibit 
clinical evidence of dispersed pigment without an associated 
elevation of IOP or optic nerve degeneration. However, as 
the disease progresses, some patients develop increased 
IOP and degeneration of the optic nerve, causing permanent 
vision loss. Recent linkage studies have identiﬁ  ed several 
genes or chromosomal loci in some types of glaucoma.10–12 In 
PDS-affected families, signiﬁ  cant linkage has been observed 
between the disease phenotype and markers located on sev-
eral chromosomal loci. GPDS1 (OMIM ID 600510) was the 
ﬁ  rst genetic locus on chromosome 7q35–q36 found to be 
associated with PDS.13
Although the GPDS1 locus may include a gene associ-
ated with NTG, an association between the GPDS1 locus 
and NTG had not been previously investigated. The purpose 
of this study is to determine whether the GPDS1 locus is 
one of the candidate loci for developing NTG. We explored 
this potential in an association study using 20 microsatellite 
markers around the GPDS1 locus.
Materials and methods
Participants
We recruited 242 Japanese participants from the Yokohama 
City University, Yamanashi University, Gifu University, Kobe 
University, Yamaguchi University, Kumamoto University, 
Hokkaido University, Tokyo University, Niigata University, 
Kanazawa University, Hiroshima University, Tajimi Municipal 
Hospital, and Tokai University in Japan. Of these participants, 
141 were diagnosed with NTG, and 101 served as controls. 
The criteria applied for the diagnosis of NTG were those 
proposed in our previous study.14 The mean patient age was 
49.2 ± 9.6 years, and the male:female ratio was 0.87. The 
mean refraction value was −3.75 ± 3.02 diopters (D), and the 
mean deviation observed in the Humphrey® static visual ﬁ  eld 
determination (Carl Zeiss Meditec, Oberkochen, Germany) 
was –10.13 ± 8.04 dB. The control participants were of the 
same age and sex as the NTG patients, and they were not 
affected by glaucoma or any local or systemic illnesses that 
could result in optic disc or visual ﬁ  eld changes. Furthermore, 
the control cases either had no myopia or had mild myopia 
with refractive errors of –3.00 D or less. All patients and 
control participants were of Japanese ethnicity, with similar 
social backgrounds and residing in the same urban area. 
Informed consent was obtained from all participants, and the 
study was conducted in accordance with the Declaration of 
Helsinki and its subsequent revisions.
Analysis of repeat polymorphisms 
for 12 microsatellite loci
Genomic DNA was extracted using the QIAamp DNA Blood 
Mini Kit (Qiagen, Hilden, Germany) or the guanidine method. In 
this association study, we selected 20 microsatellite loci that are 
located around the GPDS1 region on chromosome 7q35–36.3 
and that have been established as informative polymorphic 
genetic markers (Figure 1). The markers were determined based 
on the National Center for Biotechnology Information guide-
lines for ﬁ  ne mapping. A polymerase chain reaction (PCR) was 
performed in a reaction mixture with a total volume of 12.5 μl, 
containing PCR buffer, genomic DNA, 0.2 mM dinucleotide 
triphosphates (dNTPs), 0.5 μM primers, and 0.35 U Taq poly-
merase. The PCR conditions were as follows: 94 °C for 5 min, 
followed by 30 cycles of denaturation at 94 °C for 30 sec, 
annealing at 56 °C for 30 sec, extension at 72 °C for 1 min, and 
a ﬁ  nal elongation step at 72 °C for 10 min. The reaction was 
carried out in a PCR thermal cycler (GeneAmp System 9700, 
Applied Biosystems, Foster City, CA, USA). The forward 
primer was labeled with 6-FAM (Sigma-Aldrich, St. Louis, 
USA) at the 5´ end (Table 1). To determine the number of 
microsatellite repeats, the PCR products were denatured at 
97 °C for 2 min, mixed with formamide, and electrophoresed 
in an ABI3130 Genetic Analyzer (Applied Biosystems). The 
number of microsatellite repeats was estimated automatically 
using GeneScan 672 software (Applied Biosystems) and the 
local Southern method with a size marker of GS500 TAMRA 
(Applied Biosystems).
Statistical analysis
Allele frequencies were estimated by direct counting. The 
signiﬁ  cance of allele frequencies between the patient and 
control groups was evaluated by the Fisher’s exact test. The 
probability of association was corrected by the Bonferroni 
inequality method, ie, by multiplying the obtained P values 
with the number of alleles compared. A Pc value of 0.05 
was considered statistically signiﬁ  cant. Statistical analyses 
were performed on a computer using SPSS software (version 
10.1; SPSS Inc., Chicago, IL, USA).Clinical Ophthalmology 2009:3 309
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Results
We analyzed 20 microsatellite markers localized around 
GPDS1 for all patients and control participants (Figure 1). 
All allele frequencies were found to be in Hardy–Weinberg 
equilibrium proportion. Table 2 lists the allele frequencies 
of microsatellite markers in patients and control participants, 
with each allele designated by the size of its ampliﬁ  cation. 
The 132 allele of D7S2462 was signiﬁ  cantly associated 
with NTG, and the allele frequency was decreased in NTG 
cases as compared to controls (14.5% vs 26.2%, P = 0.0013, 
Pc = 0.019, OR = 0.48, 95% CI = 0.30–0.75). Another two 
markers, D7S2465 and D7S2423, were also negatively 
associated with the risk of NTG. On the other hand, four 
markers – D7S2546, Z67544, D7S1272i, and D7S1108i – 
were positively associated with the risk of NTG. However, 
these two negative associations and four positive associations 
did not retain statistical signiﬁ  cance after Bonferroni correc-
tion (P  0.05, Pc  0.05).
Discussion
Criteria for PDS were two of the following: midperipheral, 
radial iris transillumination defects; Krukenberg spindle; 
heavy trabecular meshwork pigmentation; and wide-open 
angle.9 Criteria for PG were PDS and two or more of three 
ﬁ  ndings: IOP greater than 21 mmHg, optic nerve damage, or 
visual ﬁ  eld loss. The probability of converting to pigmentary 
glaucoma was 10% at 5 years and 15% at 15 years. Young, 
myopic men were most likely to have pigmentary glaucoma. 
The most signiﬁ  cant risk factor for conversion to pigmentary 
glaucoma was an IOP greater than 21 mmHg at initial 
examination, whereas age, refractive error, and family history 
of glaucoma were not correlated with conversion.15
NTG is a critical and major subtype of POAG and shares 
many of the same pathologic characteristics with HTG except 
for elevated IOP. Notably, many other diseases cause atrophy 
of the optic nerve similar to that caused by NTG. Since the 
coexistence of these different diseases decreases statistical 
validation in the case-control analysis, we carefully selected 
the NTG patients using highly stringent criteria to select and 
distinguish the NTG phenotype from the other diseases that 
cause optic nerve atrophy.
The GPDS1 locus is responsible for PDS.13 An asso-
ciation between the locus and NTG, however, had not 
been previously investigated. Therefore, in this study, we 
sequenced the repeat polymorphisms of 20 microsatellite loci 
within and around the GPDS1 locus to determine whether 
these repeat polymorphisms are associated with NTG in a 
Japanese population.
The 20 microsatellite markers selected for this study 
were located almost 100–700 kb apart from each other 
on chromosome 7q35–36.3; they were chosen to achieve 
dense coverage of the regions located around GPDS1 and 
to detect susceptible loci related to NTG. As a result, a rela-
tively increased allele frequency was observed in the patient 
group for the four microsatellite markers D7S2546, Z67544, 
D7S1272i, and D7S1108i. Another three markers – D7S2462, 
D7S2465, and D7S2423 – were associated with lower 
risk of NTG. Of these markers, only D7S2462 remained 
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Figure 1 Location of 20 microsatellite markers used in this study and the genes around the GPDS1 locus. Display of genes and chromosome seven results in the UCSC 
genome browser on Human Mar.  2006 Assembly at chr7: 151,120,000–158,120,000.Clinical Ophthalmology 2009:3 310
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signiﬁ  cantly associated with NTG after Bonferroni correction 
(Pc  0.05). Therefore, there is one statistically appreciable 
difference between the NTG group and the control group in 
these 20 microsatellite markers located over a 6-Mb genomic 
region around GPDS1.
The dipeptidyl-peptidase 6 (DPP6) gene is the nearest 
gene to the D7S2462 marker. DPP6 is a type II membrane 
protein that binds voltage-gated neuronal potassium chan-
nels (A-type) and alters their expression and biophysical 
properties.16 Recently, genetic variants in DPP6 have been 
Table 1 Primers used in polymerase chain reaction for ampliﬁ  cation of microsatellite markers in this study
Location Orientationa Sequence
D7S0954i F (NED) 5´TTACATAAGGTACTTTCTGGTCAT3´
R 5´TGGTCTCCAGCTACATCAG3´
D7S0947i F (NED) 5´CTACTTTCCTGGTGTCTAGCTT3´
R 5´GATAACAGCTGATAGGTAGATCAG3´
D7S798 F (VIC) 5´AGCTGCAAAATAGTGGAAGTAG3´
R 5´CATCAATTCACATAATGACCG3´
D7S1829 F (VIC) 5´GGGGGTTTCAGAAGAGATGT3´
R 5´CCTCCAAAATTTCTGAGCAA3´
D7S2462 F (FAM) 5´GCCAAGATTGCACCACTAC3´
R 5´TGTTAAAAGTTCCCCAAGC3´
D7S0585i F (NED) 5´AATGAGCATTCTCAGTTTGAATAC3´
R 5´ATCTGGTGAACGAGTAAATAACAC3´
D7S2546 F (FAM) 5´GGAGGTTGAACAACTCTGAATAC3´
R 5´CACGCCAGGGTCTATCTT3´
D7S2447 F (NED) 5´GTCAGATGTAGGAACCAAGC3´
R 5´TCTCACTGTACTCAGCCTGT3´
Z67544 F (VIC) 5´CAACTTAAAATACGCTGTTACC3´
R 5´GCTTTTTCAGACCAAATAACTTAC3´
D7S1112i F (NED) 5´GAGAATCTAATGAAAGCTGTGG3´
R 5´TTCAGGGCATCCAAGAAG3´
D7S0952i F (NED) 5´AGATATTTGGCTAAACATGGTC3´
R 5´TCTTCAGAGATACAGAAGCAATAG3´
D7S550 F (FAM) 5´TCTCATCTGTGAATGCACTATC3´
R 5´GCAGTTGGGTTATTTCAAGTC3´
D7S1272i F (PET) 5´AATGTCCTGGAGGCTGAG3´
R 5´AAAGACTTGGTGAGACCTTCTC3´
D7S2465 F (PET) 5´ACCTGGGCAACAGAGTGAG3´
R 5´CTTCAAAGAGTTTATGCTTATGTGG3´
D7S1520i F (PET) 5´GCTGTTAGCATCTGGTTAATTTAC3´
R 5´AAACTGAAGTCTGCCATCTATTAG3´
D7S1108i F (FAM) 5´ACTTACTTATCCTACTGATCCGTG3´
R 5´TGAACCATAAATTACCTCCATTC3´
D7S1191i F (VIC) 5´CACTCTATTTGCATGGTGAAC3´
R 5´TCCAGTAGAGGGAGCTCAG3´
D7S0968i F (NED) 5´CACATCCTTTATACCTACATTCAG3´
R 5´TAATTTATCTAGAAGGTCAGCAAA3´
D7S2423 F (NED) 5´CTTCAGACCTTCAGTTGATGAT3´
R 5´GCTCTCAGACACATTTTCCA3´
D7S1159i F (VIC) 5´CTTGGAGTCAAAGAGGCC3´ 
 R 5´CTTTCCTGACTCCTTGATTAGAG3´
Note: aDye label.Clinical Ophthalmology 2009:3 311
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reported to show a signiﬁ  cant association with human neural 
diseases such as amyotrophic lateral sclerosis and autism.17–21 
Since potassium channels are considered to play an important 
role in protecting against ischemia and the development of 
apoptosis,22 DPP6 variants may act as risk factors in the 
development of NTG.
In conclusion, we performed an association analysis 
of the GPDS1 locus using microsatellite markers in NTG 
patients and found that there was an NTG-associated region 
in the GPDS1 locus. Therefore, further association studies 
using single nucleotide polymorphisms in the resistant 
region might help to identify the pathogenic gene(s) related 
to NTG.
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